Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Management of Hypercholesterolemia

Assessment and Treatment Approach

  • The American Diabetes Association recommends that LDL cholesterol of 128 mg/dL is above the optimal level but below the threshold for mandatory drug therapy in most patients without additional risk factors 1, 2
  • The American Academy of Family Physicians classifies triglycerides of 166 mg/dL as "borderline high" (150-199 mg/dL) 3
  • For patients with LDL levels between 100 and 129 mg/dL, the American Diabetes Association recommends medical nutrition therapy (MNT) before pharmacological intervention 2
  • The European Society of Cardiology states that LDL-C of 128 mg/dL does not automatically require medication therapy in the absence of other cardiovascular risk factors 4

Lifestyle Modifications and Medication Considerations

  • The American Diabetes Association recommends dietary changes focusing on reduced intake of saturated fats, trans fats, and simple carbohydrates, as well as weight loss if overweight or obese, regular physical activity, and smoking cessation if applicable 3, 6
  • The American College of Cardiology suggests that if LDL remains >130 mg/dL despite lifestyle changes, or if you have additional risk factors, medication may be considered 1, 2
  • The American College of Cardiology recommends statins as first-line therapy if medication becomes necessary, especially if LDL is the primary concern 1, 2
  • The American Heart Association states that fibrates are generally reserved for patients with more significantly elevated triglycerides (>200 mg/dL) 3

Risk Stratification and Treatment Goals

  • The American Diabetes Association recommends that for high-risk individuals, an LDL goal of <100 mg/dL or even <70 mg/dL may be appropriate, potentially requiring medication 8
  • The European Society of Cardiology suggests that the decision to treat should consider your overall cardiovascular risk, not just isolated lipid values 4
  • The American Diabetes Association states that the presence of other cardiovascular risk factors (hypertension, smoking, diabetes, family history) would lower the threshold for pharmacological intervention 6, 7